I initiate Humana at 'Buy,' viewing the CRUSH-driven selloff as an overreaction; my $562.82 DCF implies 48.1% upside. HUM is ...
Nuveen Credit and Impact Bond Fund faces persistent rate headwinds, with 8.02 years of leverage-adjusted duration and rising ...
UniFirst and Cintas CEOs are expected to meet the FTC Friday; the agency may sue to block Cintas' $5.5 billion acquisition of ...
The Kraft Heinz Company is a turnaround play, not an underpriced value stock. 12x 2026 adjusted earnings still requires the ...
The U.S. has 5,044 data centers as of October 2026, more than eight times the U.K.'s 595 and more than the next nine ...
Cheniere Energy's application to expand its Sabine Pass liquefied natural gas plant in Louisiana by 20M metric tons/year was ...
Analyst rates JOYY a Buy: $1.5 billion in dividends and buybacks through 2028 and net cash support returns, though valuation ...
Netflix is the frontrunner for U.S. 2030 and 2034 FIFA World Cup rights after Disney/ESPN and Apple opt out; FIFA bundles ...
Analyst sees BP’s turnaround as fragile and would sell on any deviation from its current path; cultural change will likely ...
The Honest Company is rated a Hold, as its turnaround is promising, but at 16x forward EBITDA, much of the upside looks ...
Analyst rates Cleveland-Cliffs a Buy: contract reforms, tariffs, and steel prices could lift 2027 EBITDA above $4 billion, ...
Biogen generated $2.8 billion in total revenue in Q3 2026, which was up 11% Y/Y. This was thanks to robust growth in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results